Literature DB >> 12417723

Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice.

Sena J Lee1, Gloria Gonzalez-Aseguinolaza, Michel C Nussenzweig.   

Abstract

To examine the physiological functions of mannose-binding lectin A (MBL-A), we generated mice that were deficient in MBL-A and examined their susceptibilities to the microbial pathogens Candida albicans and Plasmodium yoelii, an accepted experimental malaria model in mouse. We found no differences in the survival rates and fungal burdens of wild-type and MBL-A(-/-) mice with disseminated C. albicans infection. The two mouse strains were also similar in their abilities to resist hepatic accumulation of P. yoelii parasites. We conclude that MBL-A deficiency does not alter resistance to disseminated candidiasis or initial hepatic invasion by P. yoelii.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417723      PMCID: PMC134053          DOI: 10.1128/MCB.22.23.8199-8203.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Lectin-carbohydrate interactions: fine specificity difference between two mannose-binding proteins.

Authors:  R T Lee; Y Shinohara; Y Hasegawa; Y C Lee
Journal:  Biosci Rep       Date:  1999-08       Impact factor: 3.840

Review 2.  Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis.

Authors:  D L Jack; N J Klein; M W Turner
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

3.  Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR.

Authors:  O Bruña-Romero; J C Hafalla; G González-Aseguinolaza; G Sano; M Tsuji; F Zavala
Journal:  Int J Parasitol       Date:  2001-11       Impact factor: 3.981

4.  Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS.

Authors:  P Kelly; D L Jack; A Naeem; B Mandanda; R C Pollok; N J Klein; M W Turner; M J Farthing
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

Review 5.  Mannose-binding lectin: structure, function, genetics and disease associations.

Authors:  M W Turner; R M Hamvas
Journal:  Rev Immunogenet       Date:  2000

6.  Purification and characterization of two mannan-binding lectins from mouse serum.

Authors:  S Hansen; S Thiel; A Willis; U Holmskov; J C Jensenius
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

7.  Interaction of mannose-binding protein with associated serine proteases: effects of naturally occurring mutations.

Authors:  R Wallis; R B Dodd
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

8.  C-mannosylation and O-fucosylation of the thrombospondin type 1 module.

Authors:  J Hofsteenge; K G Huwiler; B Macek; D Hess; J Lawler; D F Mosher; J Peter-Katalinic
Journal:  J Biol Chem       Date:  2000-11-06       Impact factor: 5.157

9.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

10.  Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria.

Authors:  A J Luty; J F Kun; P G Kremsner
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

View more
  8 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Single-nucleotide polymorphisms in porcine mannan-binding lectin A.

Authors:  Brandon N Lillie; Natalie D Keirstead; E James Squires; M Anthony Hayes
Journal:  Immunogenetics       Date:  2006-11-07       Impact factor: 2.846

3.  Mannose-binding lectin levels and variation during invasive candidiasis.

Authors:  Sébastien Damiens; Julien Poissy; Nadine François; Julia Salleron; Samir Jawhara; Thierry Jouault; Daniel Poulain; Boualem Sendid
Journal:  J Clin Immunol       Date:  2012-07-26       Impact factor: 8.317

4.  The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites.

Authors:  Marije C Behet; Liriye Kurtovic; Geert-Jan van Gemert; Celine M Haukes; Rianne Siebelink-Stoter; Wouter Graumans; Marga G van de Vegte-Bolmer; Anja Scholzen; Jeroen D Langereis; Dimitri A Diavatopoulos; James G Beeson; Robert W Sauerwein
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

5.  A Pilot Clinical Study on Post-Operative Recurrence Provides Biological Clues for a Role of Candida Yeasts and Fluconazole in Crohn's Disease.

Authors:  Boualem Sendid; Nicolas Salvetat; Helène Sarter; Severine Loridant; Catherine Cunisse; Nadine François; Rachid Aijjou; Patrick Gelé; Jordan Leroy; Dominique Deplanque; Samir Jawhara; Dinah Weissmann; Pierre Desreumaux; Corinne Gower-Rousseau; Jean Frédéric Colombel; Daniel Poulain
Journal:  J Fungi (Basel)       Date:  2021-04-22

6.  Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.

Authors:  Eveline C van Asbeck; Andy I M Hoepelman; Jelle Scharringa; Bjorn L Herpers; Jan Verhoef
Journal:  BMC Microbiol       Date:  2008-12-18       Impact factor: 3.605

7.  Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus.

Authors:  Lei Shi; Kazue Takahashi; Joseph Dundee; Sarit Shahroor-Karni; Steffen Thiel; Jens Christian Jensenius; Faten Gad; Michael R Hamblin; Kedarnath N Sastry; R Alan B Ezekowitz
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

Review 8.  Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both?

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.